Impact of a Multidisciplinary Program in the Categorization and Management of Children With Severe Asthma
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71330 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Alvaro Teijeiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Neumonologia, Hospital Pediátrico de Córdoba, Córdoba, Argentina. Hauptthemen laut MEDLINE: Asthma, Patient Care Team. Die Arbeit nennt 22 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Asthma is an important global healthcare problem, and severe asthma affects 5%–7% of children with asthma. This small percentage results in a heavy burden of disease.
Objectives
To describe the characteristics of severe asthma patients in Argentina and their evolution over time, and to evaluate the effectiveness of a multidisciplinary team (MDT) approach in the clinical management of these children.
Methods
Prospective, observational, longitudinal study in an Argentinian Pulmonology Service.
Results
Fifty‐three children aged 5–15 years old diagnosed with severe asthma were studied over a period of 6 months; 40/53 (76%) patients were unable to access therapy (WHO Group 1) and 27/40 were finally categorized as patients with difficult‐to‐treat asthma after completing the program. The remaining 13 patients in Group 1 who were non‐responders were classified as severe therapy‐resistant asthma (STRA). Of the 13 patients who were not initially in Group 1, 8/13 were responders who no longer had severe asthma and were thus classified as difficult‐to‐treat asthma and the remaining five had STRA; thus 35/53 (66%) of the treated patients were no longer classified as severe asthma after completing the program. We identified adverse psychosocial factors identified in 47%. 77% had allergic rhinitis. Most had normal spirometry. Blood eosinophil count was median of 320 cell/µL, and median total IgE was 313 UI/ml. During the program, asthma symptoms, quality of life and asthma exacerbations all improved significantly.
Conclusion
Our multidisciplinary approach was associated with better outcomes in most patients with severe asthma. This model could profitably be adopted in other low‐resource settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Neumonologia, Hospital Pediátrico de Córdoba, Córdoba, Argentina.
- Cátedra de Inmunología y Fisiologia Humana, Carrera de Mecidina, Facultad de Ciencias de la Salud, Universidad Católica de Córdoba, Córdoba, Argentina.
- Departamento de Alergia e Immunología, Hospital Pediátrico de Córdoba, Córdoba, Argentina.
- Laboratorio de Función Pulmonar, Hospital Pediátrico de Córdoba, Córdoba, Argentina.
- Escuela de Kinesiología y Fisioterapia, Facultad de Ciencias Médicas, Universidad Nacional Córdoba, Córdoba, Argentina.
- Departamento de Salud Mental, Pediatric Hospital of Córdoba, Córdoba, Argentina.
ORCID-Profile: Alvaro Teijeiro
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Teijeiro, A., Gómez, S., Grenat, A., Bustos, C., Morales, B., Prunier, M., Hernandez, L., & Bush, A. (2025). Impact of a Multidisciplinary Program in the Categorization and Management of Children With Severe Asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71330
Vancouver
Teijeiro A, Gómez S, Grenat A, Bustos C, Morales B, Prunier M, et al. Impact of a Multidisciplinary Program in the Categorization and Management of Children With Severe Asthma. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71330
BibTeX
@article{Teijeiro2025,
author = {Teijeiro, Alvaro and Gómez, Silvia and Grenat, Andrés and Bustos, Carolina and Morales, Benigno and Prunier, Mariana and Hernandez, Ludmila and Bush, Andrew},
title = {Impact of a Multidisciplinary Program in the Categorization and Management of Children With Severe Asthma},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71330}
}
EUVIMED